Psychotic and mood disorders associated with the perimenopausal period: Epidemiology, aetiology and management

CNS Drugs

Volumn 15, Issue 3, 2001, Pages 175-184

  Robinson, Gail Erlick ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CONJUGATED ESTROGEN; NEUROLEPTIC AGENT; PROGESTERONE;

AFFECTIVE NEUROSIS; ALGORITHM; CLIMACTERIUM; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HORMONE SUBSTITUTION; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SOCIAL ASPECT; TARDIVE DYSKINESIA; THEORY;

AFFECTIVE DISORDERS, PSYCHOTIC; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; PREMENOPAUSE;

EID: 0035066782     PISSN: 11727047     EISSN: None     Source Type: Journal    
DOI: 10.2165/00023210-200115030-00002     Document Type: Review

References (53)

1. Some neuroses of the menopause
2. The myth of involutional melancholia
3. Menopausal symptoms in women of various ages
4. The menopausal syndrome
5. The perimenopausal symptoms
6. Study of symptoms in middle life with special reference to the menopause
7. Menopause-related affective disorders; a justification for further study
8. The perimenopause and affective disorders
9. Sex and depression in the National Comorbidity Survey I. Lifetime prevalence, chronicity and recurrence
10. The relative contributions of endocrine changes and social circumstances to depression in mid-aged women
11. Menopause, early aging and elderly women
12. Binding and metabolism of sex steroids by the hypthalamic-pituitary unit: Physiological implications
13. High affinity binding of antidepressants to biogenic amine transport sites in human brain and platelet: Studies in depression
14. Hormones, mood and cognitive functioning in postmenopausal women
15. Maternal immunological mechanisms during pregnancy
16. Hormones, mood and neurobiology: A summary
17. The impact of different doses of estrogen and progestin on mood and sexual behaviour in postmenopausal women
18. Gender, brain and schizophrenia
19. Puberty and the onset of psychosis
20. Psychologic distress during menopause: Associations across the reproductive life cycle
21. Patterns of depressed mood in midlife women: Observations from the Seattle Midlife Women's Health Study
22. A longitudinal analysis of the association between menopause and depression: Results from the Massachusetts Women's Health Study
23. Cross-cultural aspects of menopause
24. Women wth bipolar illness: Clinical and research issues
25. Course of the manic-depressive cycle and changes caused by treatments
26. Female depression before and after menopause
27. The impact of gender on understanding the epidemiology of schizophrenia
28. Antagonism of dopamine supersensitivity by estrogen: Neurochemical studies in an animal model of tardive dyskinesia
29. Estrogen receptor activation and tardive dyskinesia
30. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopause women
31. A meta-analysis of the effect of hormone replacement therapy upon depressed mood
32. Affective changes with estrogen and androgen replacement therapy in surgically menopausal women
33. Estrogen improves psychological function in asymptomatic post-menopausal women
34. Double-blind, placebocontrolled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression
35. Estrogen therapy for severe persistent depressions in women
36. Estrogen replacement in perimenopause-related depression: A preliminary report
37. Individual differences in changes in mood and platelet monamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women
38. Lack of efficacy of estrogen supplementation to imipramine in resistant female depressives
39. Fluoxetine efficacy in menopausal women with or without estrogen replacement
40. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial
41. Tricyclic induced akathisia in patients taking conjugated estrogens
42. Oestrogens and extrapyramidal system
43. Gender differences in treatment response in schizophrenia
44. Hormone replacement therapy
45. Psychological treatments
46. Psychoeducational and support groups at transition to menopause